0001225208-23-002378.txt : 20230221
0001225208-23-002378.hdr.sgml : 20230221
20230221161932
ACCESSION NUMBER: 0001225208-23-002378
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230216
FILED AS OF DATE: 20230221
DATE AS OF CHANGE: 20230221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mirviss Jeffrey B.
CENTRAL INDEX KEY: 0001566094
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 23648435
MAIL ADDRESS:
STREET 1: C/O BOSTON SCIENTIFIC CORPORATION
STREET 2: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
4
1
doc4.xml
X0306
4
2023-02-16
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001566094
Mirviss Jeffrey B.
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
EVP&Pres, Periph Intervent
Common Stock
2023-02-16
4
M
0
2970.0000
0.0000
A
92858.0000
D
Common Stock
2023-02-16
4
F
0
909.0000
46.4800
D
91949.0000
D
Common Stock
2023-02-16
4
S
0
1409.0000
46.7900
D
90540.0000
D
Common Stock
2023-02-17
4
M
0
3333.0000
0.0000
A
93873.0000
D
Common Stock
2023-02-17
4
F
0
1020.0000
46.5400
D
92853.0000
D
Common Stock
2023-02-17
4
S
0
2061.0000
46.3500
D
90792.0000
D
Common Stock
2023-02-18
4
M
0
2817.0000
0.0000
A
93609.0000
D
Common Stock
2023-02-18
4
F
0
1002.0000
46.5400
D
92607.0000
D
Restricted Stock Units
2023-02-16
4
M
0
2970.0000
0.0000
D
2026-02-16
Common Stock
2970.0000
8910.0000
D
Restricted Stock Units
2023-02-17
4
M
0
3333.0000
0.0000
D
2025-02-17
Common Stock
3333.0000
6667.0000
D
Deferred Stock Units
2023-02-18
4
M
0
2817.0000
0.0000
D
2024-02-18
Common Stock
2817.0000
2817.0000
D
Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock.
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.
/s/ Susan Thompson, Attorney-in-Fact
2023-02-20